4.5 Article

Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease

期刊

CLINICAL BIOCHEMISTRY
卷 43, 期 3, 页码 267-271

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.clinbiochem.2009.08.021

关键词

Dementia; Oxidative stress; Protein oxidation; Antioxidant

资金

  1. Alzheimer's Society

向作者/读者索取更多资源

Objectives: The two most common forms of dementia are Alzheimer's disease (AD), and vascular dementia (VaD). In the overlap of biochemical processes which have been identified in AD and VaD, oxidative stress is believed to contribute to the numerous pathologies of both dementias. Design and methods: This study assessed oxidative damage in total plasma proteins, and isolated LDL in AD patients and age matched controls, in addition total antioxidant capacity (TAC) was measured. Results: Significantly higher LDL protein carbonylation was observed in AD compared to age-matched controls (AD: 4.17 +/- 0.73 vs. control: 3.85 +/- 0.86 m-nol/ing LDL; p=0.05, 2-tailed Mann-Whitney), in addition to reduced TAC (AD: 924.708 +/- 174.429 vs. control: 1078.536 +/- 252.633 mu M; p=0.001, 2-tailed Mann-Whitney). No differences were seen in total plasma protein carbonyl content (AD: 3.88 +/- 0.31 vs. control: 3.98 +/- 0.48 nmol/mg protein). Conclusion: The results further support the view that oxidation events in AD may be specific in nature, and represent functional changes to proteins, rather than random global events. (C) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cell Biology

The impact of aging in dementia: It is time to refocus attention on the main risk factor of dementia

Patrizia Mecocci, Virginia Boccardi

Summary: This passage challenges the traditional view that amyloid is the leading cause of AD, proposing instead that the progressive decline in brain energy levels during aging is the main risk factor for dementia in older individuals. It suggests that optimizing brain energetics should be a key component in future strategies for preventing and treating dementia.

AGEING RESEARCH REVIEWS (2021)

Article Clinical Neurology

The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease

Joel Simren, Antoine Leuzy, Thomas K. Karikari, Abdul Hye, Andrea Lessa Benedet, Juan Lantero-Rodriguez, Niklas Mattsson-Carlgren, Michael Scholl, Patrizia Mecocci, Bruno Vellas, Magda Tsolaki, Iwona Kloszewska, Hilkka Soininen, Simon Lovestone, Dag Aarsland, Oskar Hansson, Pedro Rosa-Neto, Eric Westman, Kaj Blennow, Henrik Zetterberg, Nicholas J. Ashton

Summary: P-tau181 shows potential as an effective diagnostic and prognostic biomarker in AD, detecting the disease at MCI and dementia stages and being strongly associated with cognitive decline and gray matter loss.

ALZHEIMERS & DEMENTIA (2021)

Article Clinical Neurology

Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease

Luke Whiley, Katie E. Chappell, Ellie D'Hondt, Matthew R. Lewis, Beatriz Jimenez, Stuart G. Snowden, Hilkka Soininen, Iwona Kloszewska, Patrizia Mecocci, Magda Tsolaki, Bruno Vellas, Jonathan R. Swann, Abdul Hye, Simon Lovestone, Cristina Legido-Quigley, Elaine Holmes

Summary: The study found significantly lower concentrations of tryptophan pathway metabolites in the AD group, while higher concentrations of indoleamine pathway metabolites were observed. Concentrations of various metabolites showed a decreasing trend with clinical diagnosis: control > MCI > AD. There were no significant differences between the two MCI subgroups, and the use of SSRI medication influenced serum observations but not urine results.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Clinical Neurology

Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe

Marina Boccardi, Andreas U. Monsch, Clarissa Ferrari, Daniele Altomare, Manfred Berres, Isabelle Bos, Andreas Buchmann, Chiara Cerami, Mira Didic, Cristina Festari, Valentina Nicolosi, Leonardo Sacco, Liesbeth Aerts, Emiliano Albanese, Jean-Marie Annoni, Nicola Ballhausen, Christian Chicherio, Jean-Francois Demonet, Virginie Descloux, Suzie Diener, Daniel Ferreira, Jean Georges, Anton Gietl, Nicola Girtler, Ingo Kilimann, Stefan Kloppel, Nicole Kustyniuk, Patrizia Mecocci, Nathalie Mella, Martina Pigliautile, Katrin Seeher, Steven D. Shirk, Alessio Toraldo, Andrea Brioschi-Guevara, Kwun C. G. Chan, Paul K. Crane, Alessandra Dodich, Alice Grazia, Nicole A. Kochan, Fabricio Ferreira de Oliveira, Flavio Nobili, Walter Kukull, Oliver Peters, Inez Ramakers, Perminder S. Sachdev, Stefan Teipel, Pieter Jelle Visser, Michael Wagner, Sandra Weintraub, Eric Westman, Lutz Froelich, Henry Brodaty, Bruno Dubois, Stefano F. Cappa, David Salmon, Bengt Winblad, Giovanni B. Frisoni, Matthias Kliegel

Summary: An expert consensus has been reached on harmonizing the diagnosis of neurocognitive disorders across European countries and potentially beyond, by defining a standardized assessment battery and methodology for obtaining consistent normative data.

ALZHEIMERS & DEMENTIA (2022)

Correction Neurosciences

Rationale, Design, and Methodology of a Prospective Cohort Study for Coping with Behavioral and Psychological Symptoms of Dementia: The RECage Project (vol 80, pg 1613, 2021)

Eleni Poptsi, Magda Tsolaki, Sverre Bergh, Bruno Mario Cesana, Alfonso Ciceone, Andrea Fabbo, Giovanni B. Frisoni, Lutz Froelich, Anna Giulia Guazzarini, Jacques Hugon, Sara Fascendini, Sara Lavolpe, Patrizia Mecocci, Oliver Peters, Carlo Alberto Defanti

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Cell Biology

Senotherapeutics: Targeting senescent cells for the main age-related diseases

Virginia Boccardi, Patrizia Mecocci

Summary: This review summarizes the current knowledge on targeting senescent cells to reduce the risk of age-related diseases, including the use of senotherapeutic strategies and drugs. Research suggests that senotherapeutic approach may be translatable to humans, but caution is needed due to a lack of evidence of potential side-effects of senolytic agents.

MECHANISMS OF AGEING AND DEVELOPMENT (2021)

Article Biochemistry & Molecular Biology

Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease

Mary Ann A. DeMichele-Sweet, Lambertus Klei, Byron Creese, Janet C. Harwood, Elise A. Weamer, Lora McClain, Rebecca Sims, Isabel Hernandez, Sonia Moreno-Grau, Lluis Tarraga, Merce Boada, Emilio Alarcon-Martin, Sergi Valero, Yushi Liu, Basavaraj Hooli, Dag Aarsland, Geir Selbaek, Sverre Bergh, Arvid Rongve, Ingvild Saltvedt, Havard K. Skjellegrind, Bo Engdahl, Eystein Stordal, Ole A. Andreassen, Srdjan Djurovic, Lavinia Athanasiu, Davide Seripa, Barbara Borroni, Diego Albani, Gianluigi Forloni, Patrizia Mecocci, Alessandro Serretti, Diana De Ronchi, Antonis Politis, Julie Williams, Richard Mayeux, Tatiana Foroud, Agustin Ruiz, Clive Ballard, Peter Holmans, Oscar L. Lopez, M. Ilyas Kamboh, Bernie Devlin, Robert A. Sweet

Summary: Psychotic symptoms in Alzheimer's disease are common and have genetic components, with significant associations found in two loci - ENPP6 and SUMF1. AD + P shows negative genetic correlations with cognitive and educational attainment, and positive genetic correlations with depressive symptoms. This study provides insights into the genetic architecture of psychosis in Alzheimer's disease.

MOLECULAR PSYCHIATRY (2021)

Editorial Material Biochemistry & Molecular Biology

Editorial for the Special Issue Molecular Bases of Senescence

Giorgio Fano-Illic, Stefania Fulle, Patrizia Mecocci

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Modeling the dynamics of energy imbalance: The free radical theory of aging and frailty revisited

Maria Cristina Polidori, Patrizia Mecocci

Summary: This review explores the role of oxidative stress in aging and frailty, highlighting the need for effective management strategies to prevent and address frailty.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Article Nutrition & Dietetics

Metabolic Score for Insulin Resistance (METS-IR) and Circulating Cytokines in Older Persons: The Role of Gender and Body Mass Index

Virginia Boccardi, Francesca Mancinetti, Marta Baroni, Roberta Cecchetti, Patrizia Bastiani, Carmelinda Ruggiero, Patrizia Mecocci

Summary: The study found that plasma levels of EGF, Eotaxin, and MCP-1 are closely associated with insulin resistance in women, with BMI being a significant mediator. This suggests that the association between cytokines and insulin resistance is gender-specific.

NUTRIENTS (2022)

Article Nutrition & Dietetics

miRNAs and Alzheimer's Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population

Virginia Boccardi, Giulia Poli, Roberta Cecchetti, Patrizia Bastiani, Michela Scamosci, Marta Febo, Emanuela Mazzon, Stefano Bruscoli, Stefano Brancorsini, Patrizia Mecocci

Summary: Alzheimer's disease (AD) is the leading cause of dementia globally and is a major contributor to disability in older individuals. Vitamin E levels are lower in AD patients, and inflammation and microRNAs also play significant roles in the development of AD. MiR-122 may be a modulating factor, correlating with alpha-tocopherol and inflammation molecules.

NUTRIENTS (2023)

Editorial Material Geriatrics & Gerontology

Intermediate Care in Italy: Addressing the Challenges and Opportunities for Person-Tailored Care

Virginia Boccardi, Patrizia Mecocci

Summary: The concept of intermediate care is increasingly recognized in Italy as a critical strategy to improve healthcare quality and integration across different settings. Person-tailored care is a key challenge, requiring a shift towards a holistic approach that prioritizes individual preferences and values. This necessitates greater collaboration, communication, and innovation in care delivery, including the use of technology for remote monitoring. Despite challenges, intermediate care offers significant opportunities to enhance care quality, reduce costs, and promote social cohesion and community engagement.

GERIATRICS (2023)

Article Engineering, Electrical & Electronic

AI-Based Predictive Modelling of the Onset and Progression of Dementia

Sten Hanke, Francesca Mangialasche, Markus Bodenler, Bernhard Neumayer, Tiia Ngandu, Patrizia Mecocci, Helena Untersteiner, Elisabeth Stogmann

Summary: Dementia prevention is a global public health priority. The FINGER study in Finland has shown that dementia risk can be reduced through non-pharmacological interventions. The LETHE project aims to provide a digital-enabled intervention model for delaying or preventing cognitive decline.

SMART CITIES (2022)

Article Geriatrics & Gerontology

User experience and acceptance of a device assisting persons with dementia in daily life: a multicenter field study

Theresa Koenig, Martina Pigliautile, Oscar Aguila, Jon Arambarri, Christophoros Christophorou, Matteo Colombo, Argyris Constantinides, Rosario Curia, Kathrina Dankl, Sten Hanke, Christopher Clemens Mayer, Stefan Moritsch, Markus Muellner-Rieder, Fritz Pernkopf, Christian Schueler, Maria Stillo, Patrizia Mecocci, Elisabeth Stoegmann

Summary: The study evaluated an assistive system prototype for dementia patients, showing that a positive attitude towards technology is crucial for successful implementation regardless of age. Frequent use was correlated with a positive attitude towards technology, and participants showed great interest in digital solutions, believing that technological systems will help maintain independence for individuals with cognitive dysfunction in the future.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)

Article Geriatrics & Gerontology

Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 project

Virginia Boccardi, Valentina Bubba, Ilenia Murasecco, Martina Pigliautile, Roberto Monastero, Roberta Cecchetti, Michela Scamosci, Patrizia Bastiani, Patrizia Mecocci

Summary: The study found that serum alkaline phosphatase (ALP) levels were significantly higher in the Subjective Cognitive Decline (SCD) group compared to the healthy control group, and were inversely correlated with cognitive functions, especially with attentional matrices and letter fluency tests.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)

暂无数据